An assessment of the first 3 years' use of Implanon® in Luton

被引:30
作者
Agrawal, A
Robinson, C
机构
[1] SE Hertfordshire Primary Care Trust, Welwyn Garden City, Herts, England
[2] Southwark PCT, London, England
关键词
D O I
10.1783/147118905774480581
中图分类号
D669 [社会生活与社会问题]; C913 [社会生活与社会问题];
学科分类号
1204 ;
摘要
Objectives Implanon (R) was introduced in the UK in September 1999. We present here the results of our first 106 Implanon insertions, performed over a period of 18 months. The aims of the study were to study the clinical and demographic profile of Implanon users, to assess the continuation rates of Implanon in the local population, and to identify the reasons for removal. Methods This was a case note-based study in which the data were transferred to a standardised pre-tested proforma. Results The age range of the 106 Implanon users was 15-43 years. Eighty-six of these clients had their Implanon removed and the Implanon status of 20 clients is not known since they were lost to follow-up by our service. Of these 86 cases, 26 had completed the full 3-year period; therefore, the continuation rate at 3 years was 30.2%. The continuation rate at the end of 1 year was 69.8% and at 2 years was 44.1%. Of the 60 women who had their Implanon removed before the recommended 3-year period, the most common reason was for bleeding irregularity (24 cases, 40%). Conclusions This is the first published study set in the UK within a real-life setting to follow up a cohort of Implanon users for the full 3-year period. No contraceptive failures were found, replicating previous clinical trials. The continuation rate in this real-life situation was quite low compared to clinical trials. This is frequently the case when comparing real-life situations with clinical trials and may be in part due to higher motivation on the part of clinical trial participants.
引用
收藏
页码:310 / 312
页数:3
相关论文
共 10 条
[1]   RETRACTED: An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon® (Retracted Article) [J].
Affandi, B .
CONTRACEPTION, 1998, 58 (06) :99S-107S
[2]   Spontaneous snapping of an Implanon® in two halves in situ [J].
Agrawal, A ;
Robinson, C .
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2003, 29 (04) :238-238
[3]   A multicentre efficacy and safety study of the single contraceptive implant Implanon® [J].
Croxatto, HB ;
Urbancsek, J ;
Massai, R ;
Bennink, HC ;
van Beek, A .
HUMAN REPRODUCTION, 1999, 14 (04) :976-981
[4]   RETRACTED: The pharmacodynamics and efficacy of Implanon® - An overview of the data (Retracted Article) [J].
Croxatto, HB ;
Mäkäräinen, L .
CONTRACEPTION, 1998, 58 (06) :91S-97S
[5]   RELEASE CHARACTERISTICS, OVARIAN ACTIVITY AND MENSTRUAL BLEEDING PATTERN WITH A SINGLE CONTRACEPTIVE IMPLANT RELEASING 3-KETODESOGESTREL [J].
DAVIES, GC ;
FENG, LX ;
NEWTON, JR ;
VANBEEK, A ;
COELINGHBENNINK, HJT .
CONTRACEPTION, 1993, 47 (03) :251-261
[6]  
Edwards J E, 1999, Br J Fam Plann, V24, P3
[7]   Persistent vaginal bleeding in a patient with a broken Implanon® [J].
Pickard, S .
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2002, 28 (04) :207-208
[8]  
Power Jo, 2002, Practitioner, V246, P335
[9]   Experience with implanon® in a northeast London family planning clinic [J].
Rai, K ;
Gupta, S ;
Cotter, S .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2004, 9 (01) :39-46
[10]   An assessment of the use of Implanon® in three community services [J].
Smith, A ;
Reuter, S .
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2002, 28 (04) :193-196